Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation-Reference-Cited by-同舟云学术

Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation

Published:2021-04 Issue:4 Volume:24 Page:102331
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Diallo Katy,Simons Numa,Sayegh Souraya,Baron Michel,Degboé Yannick,Boyer Jean-Frédéric,Kruglov Andrey,Nedospasov Sergei,Novarino Julien,Aloulou Meryem,Fazilleau Nicolas,Constantin Arnaud,Cantagrel Alain,Davignon Jean-Luc,Rauwel Benjamin

Funder

Région Midi-Pyrénées

INSERM

CNRS

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference53 articles.

1. TNF neutralization results in the delay of transplantable tumor growth and reduced MDSC accumulation;Atretkhany;Front. Immunol.,2016

2. Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes;Boyer;Arthritis Res. Ther.,2007

3. Anti-TNF certolizumab pegol induces antioxidant response in human monocytes via reverse signaling;Boyer;Arthritis Res. Ther.,2016

4. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist;Butler;Eur. Cytokine Netw.,1995

5. The survival effect of TNF-α in human neutrophils is mediated via NF-κB-dependent IL-8 release;Cowburn;Eur. J. Immunol.,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating and Synovial Monocytes in Arthritis and Ex-Vivo Model to Evaluate Therapeutic Modulation of Synovial Monocytes;Immunological Investigations;2023-08-24

2. Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis;Frontiers in Immunology;2022-02-23

3. Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer;International Journal of Molecular Sciences;2022-01-28

4. The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation;Frontiers in Immunology;2021-07-07